(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BT

ST13

US500000088910081

Class

5, 42

Filing

88910081

Registration

6821655

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

08/16/2022

Trademark type

Combined

Nice classes

5, 42

Filing date

05/11/2020

Registration date

08/16/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/16/2022

Last transaction

08/16/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2017-05-00

First use in commerce

2017-05-00

Drawing code

3

Owner type

03

Owner location

New Haven, CT

Examiner

SWAIN, MICHELE LYNN

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of stylized letters "b" and "t".

Holders and representatives

Holders

Bioxcel Therapeutics, Inc.

Representatives

Brendan J. Hughes COOLEY LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations in the field of immuno-oncology; pharmaceutical preparations for the treatment of neurological conditions

Class 42

Pharmaceutical research and development in the fields of neuroscience and immuno-oncology

Publications

History of USPTO decisions and trademark events.

27 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/16/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

08/16/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/12/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/11/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/27/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/27/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/27/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/31/2022

GNRT

NON-FINAL ACTION E-MAILED

01/31/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

01/31/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/03/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/05/2021

EX1G

SOU EXTENSION 1 GRANTED

05/04/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/04/2021

IUAF

USE AMENDMENT FILED

04/20/2021

EXT1

SOU EXTENSION 1 FILED

04/20/2021

EEXT

SOU TEAS EXTENSION RECEIVED

04/20/2021

EISU

TEAS STATEMENT OF USE RECEIVED

04/20/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/20/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/25/2020

PUBO

PUBLISHED FOR OPPOSITION

08/25/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/05/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/23/2020

DOCK

ASSIGNED TO EXAMINER

07/16/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/23/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/22/2020

NWAP

NEW APPLICATION ENTERED

05/14/2020

Continuous trademark protection

Get notified about every new filing that threatens BT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.